Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy

Circulation: Cardiovascular Imaging

Volumn 5, Issue 4, 2012, Pages 441-447

  Maron, Martin S ^a   Rowin, Ethan J ^a   Lin, David ^b   Appelbaum, Evan ^c   Chan, Raymond H ^c   Gibson, C Michael ^c   Lesser, John R ^b   Lindberg, Jana ^b   Haas, Tammy S ^b   Udelson, James E ^a   Manning, Warren J ^c   Maron, Barry J ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular magnetic resonance; Crypts; Hypertrophic cardiomyopathy

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIAC IMAGING; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; FEMALE; GENOTYPE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL CRYPT; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; SARCOMERE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; GENOTYPE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MINNESOTA; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84867157026     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.112.972760     Document Type: Article

References (24)

1. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Panse N, Weil J, Zenovich A, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation. 2005;112:855-861. (Pubitemid 32906552)
2. Maron MS, Lesser JR, Maron BJ. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance. Am J Cardiol. 2010;105:1842-1843. (Pubitemid 46661480)
3. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004;90:645-649. (Pubitemid 40446439)
4. Pennell DJ. Cardiovascular magnetic resonance. Circulation. 2010;121: 692-705.
5. Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udelson JE, Ackerman MJ, Maron BJ. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation. 2008;118:1541-1549. (Pubitemid 29140917)
6. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54:220-228. (Pubitemid 36760780)
7. Fattori R, Biagini E, Lorenzini M, Buttazzi K, Lovato L, Rapezzi C. Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol. 2010;105:1592-1596.
8. Holloway CJ, Betts TR, Neubauer S, Myerson SG. Hypertrophic cardiomyopathy complicated by large apical aneurysm and thrombus, presenting as ventricular tachycardia. J Am Coll Cardiol. 2010;56:1961.
9. Germans T, Dijkmans PA, Wilde AA, Kamp O, van Rossum AC. Images in cardiovascular medicine. Prominent crypt formation in the inferoseptum of a hypertrophic cardiomyopathy mutation carrier mimics noncompaction cardiomyopathy. Circulation. 2007;115:e610-611. (Pubitemid 44629154)
10. Germans T, Wilde AA, Dijkmans PA, Chai W, Kamp O, Pinto YM, van Rossum AC. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol. 2006;48:2518-2523. (Pubitemid 16081435)
11. Johansson B, Maceira AM, Babu-Narayan SV, Moon JC, Pennell DJ, Kilner PJ. Clefts can be seen in the basal inferior wall of the left ventricle and the interventricular septum in healthy volunteers as well as patients by cardiovascular magnetic resonance. J Am Coll Cardiol. 2007;50:1294-1295.
12. Maron BJ, Lindberg J, Lesser JR. Ventricular septal crypt in hypertrophic cardiomyopathy. Eur Heart J. 2010;31:1923.
13. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH III, Spirito P, Ten Cate FJ, Wigle ED; Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-1713.
14. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology. 2011;258:128-133.
15. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol. 2005;96:270-275.
16. Panza JA, Maron BJ. Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood. Am J Cardiol. 1989;63:1258-1265.
17. Strijack B, Ariyarajah V, Soni R, Jassal DS, Greenberg CR, McGregor R, Morris M. Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson. 2008;10:58. (Pubitemid 28446654)
18. Ho CY, Lopez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonzalez A, Colan SD, Seidman JG, Diez J, Seidman CE. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363:552-563.
19. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation. 2002;105:2992-2997.
20. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128-130.
21. Kuribayashi T, Roberts WC. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol. 1992;70:1333-1340. (Pubitemid 28280383)
22. Whittaker P, Romano T, Silver MD, Boughner DR. An improved method for detecting and quantifying cardiac muscle disarray in hypertrophic cardiomyopathy. Am Heart J. 1989;118:341-346. (Pubitemid 36627288)
23. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958;20:1-8.
24. Stollberger C, Finsterer J. Left ventricular hypertrabeculation/ noncompaction. J Am Soc Echocardiogr. 2004;17:91-100. (Pubitemid 38647940)